Status:

COMPLETED

The Effect of Efudex Treatment on Photoaged Skin

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

Bausch Health Americas, Inc.

Conditions:

Photo-aging

Keratosis

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The researchers propose that skin improvements may be seen following a course of Efudex, (5-fluorouracil), a FDA-approved topical therapy (applied directly to the skin). These improvements could be th...

Detailed Description

Efudex (5-fluorouracil) has been used as topical chemotherapy for the treatment of actinic keratoses (AKs) since the 1950's. Through many years of use, Efudex has been deemed to be a safe and effectiv...

Eligibility Criteria

Inclusion

  • Age 50 or older of either gender.
  • Patients must have actinic keratoses
  • Patients must have clinical photoaging judged by rhytides, dyspigmentation, poikiloderma, lentigines, skin thinning, and/or telangiectases.
  • Subjects must be in generally good health and willing to undergo skin biopsies from the face.
  • Subjects must be willing and able to comply with the requirements of the protocol.
  • You must live within a reasonable driving distance of Ann Arbor, Michigan, and/or be able to attend all of the scheduled appointments during the study.

Exclusion

  • Oral retinoid therapy (such as Accutane) within two months of study entry.
  • Topical retinoid, imiquimod, or diclofenac therapy within 2 months of study entry.
  • Prior laser re-surfacing, chemical peels for actinic keratoses or aging skin.
  • Pregnant or nursing subjects.
  • Non-compliant subjects.
  • Subjects with a significant medical history or concurrent illness that the investigator feels is not safe for study participation.
  • Prior systemic treatment with 5-fluorouracil.
  • Known history of allergy to lidocaine (numbing medication), 5-fluoruracil, or any other known components of Efudex.

Key Trial Info

Start Date :

July 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT00121511

Start Date

July 1 2005

End Date

July 1 2007

Last Update

May 27 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan Department of Dermatology

Ann Arbor, Michigan, United States, 48109